Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
방광암 환자에서 방광 내 치료의 현재와 미래open accessThe Present and Future of Intravesical Therapy in Bladder Cancer
- Issue Date
- May-2022
- Publisher
- 대한비뇨기종양학회
- Keywords
- Intravesical treatment; Bladder cancer; Urothelial carcinoma
- Citation
- 대한비뇨기종양학술지, v.20, no.2, pp 82 - 91
- Pages
- 10
- Journal Title
- 대한비뇨기종양학술지
- Volume
- 20
- Number
- 2
- Start Page
- 82
- End Page
- 91
- ISSN
- 2234-4977
- Abstract
- Intravesical therapy is the gold standard in the treatment of nonmuscle invasive bladder cancer (NMIBC). Despite the efficacy of intravesical therapies, the best treatment options are not determined yet. Development in research of bladder cancer shows several new intravesical drugs and its delivery systems. Additionally, the novel knowledge of bladder cancer immune reaction improves and provides ambitious treatment strategies. The future of NMIBC therapy will be changed by the development of immunotherapy and new technologies for device-assisted treatment. This review focuses on recent advances in the intravesical therapy of NMIBC, viral gene therapy, new technology of intravesical chemotherapy, and drug delivery system.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.